A fibrin gel loaded with chitosan nanoparticles for local delivery of rhEGF: Preparation and in vitro release studies

Journal of Materials Science: Materials in Medicine

Volumn 22, Issue 5, 2011, Pages 1221-1230

  Zhou, Wenjun ^a   Zhao, Min ^a   Zhao, Yuan ^a   Mou, Yan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL EFFECTS; CHITOSAN NANOPARTICLES; CONTROLLABLE RELEASE; DELIVERY SYSTEMS; FIBRIN GELS; IN-VITRO; LOCAL DELIVERY; POTENTIAL APPLICATIONS; PREPARATION PROCESS; RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR (RHEGF); RELEASE RATE; SUSTAINED RELEASE; WOUND HEALING; WOUND SITE;

BIOACTIVITY; CELL PROLIFERATION; CHITOSAN; GELS; SYNCHROTRONS;

NANOPARTICLES;

CHITOSAN; FIBRIN; NANOPARTICLE; RECOMBINANT EPIDERMAL GROWTH FACTOR;

ARTICLE; CELL LINE; CELL PROLIFERATION; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RELEASE; IN VITRO STUDY; NONHUMAN; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; BALB 3T3 CELLS; CELL PROLIFERATION; CHITOSAN; EPIDERMAL GROWTH FACTOR; FIBRIN; FIBROBLASTS; GELS; HUMANS; MICE; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; RECOMBINANT PROTEINS;

EID: 80051671844     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-011-4304-9     Document Type: Article

References (37)

1. DiBiase MD, Rhodes CT. The design of analytical methods for use in topical epidermal growth factor product development. J Pharm Pharmacol. 1991;43(8):553-8.
2. Kitajima T, Sakuragi M, Hasuda H, Ozu T, Ito Y. A chimeric epidermal growth factor with fibrin affinity promotes repair of injured keratinocyte sheets. Acta Biomater. 2009;5(7):2623-32.
3. Grazul-Bilska AT, Johnson ML, Bilski JJ, Redmer DA, Reynolds LP, Abdullah A, et al. Wound healing: the role of growth factors. Drugs Today. 2003;39(10):787-800. (Pubitemid 37500405)
4. Mössner J, Caca K. Developments in the inhibition of gastric acid secretion. Eur J Clin Invest. 2005;35(8):469-75. (Pubitemid 41153200)
5. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 1999;7(6):442-52. (Pubitemid 30027566)
6. Kim EY, Gao ZG, Park JS, Li H, Han K. rhEGF/HP-[beta]-CD complex in poloxamer gel for ophthalmic delivery. Int J Pharm. 2002;233(1-2):159-67. (Pubitemid 34230428)
7. Schneider A, Wang XY, Kaplan DL, Garlick JA, Egles C. Biofunctionalized electrospun silk mats as a topical bioactive dressing for accelerated wound healing. Acta Biomater. 2009;5(7):2570-8.
8. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release. 2004;100(1):5-28. (Pubitemid 39445982)
9. Mourya VK, Inamdar NN. Trimethyl chitosan and its applications in drug delivery. J Mater Sci Mater Med. 2009;20(5):1057-79.
10. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B. 2010;75(1):1-18.
11. Zhang XG, Teng DY, Wu ZM, Wang X, Wang Z, Yu DM, et al. PEG-grafted chitosan nanoparticles as an injectable carrier for sustained protein release. J Mater Sci Mater Med. 2008;19(12):3525-33.
12. Hasanovic A, Zehl M, Reznicek G, Valenta C. Chitosan-tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability. J Pharm Pharmacol. 2009;61(12):1609-16.
13. Sakiyama-Elbert SE, Hubbell JA. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell in growth matrix. J Control Release. 2000;69(1):149-58.
14. Kaufman MR, Westreich R, Ammar SM, Amirali A, Iskander A, Lawson W. Autologous cartilage grafts enhanced by a novel transplant medium using fibrin sealant and fibroblast growth factor. Arch Facial Plast Surg. 2004;6(2):94-100.
15. Zisch AH, Schenk U, Schense JC, Sakiyama-Elbert SE, Hubbell JA. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release. 2001;72(1-3):101-13. (Pubitemid 32522348)
16. Giannoni P, Hunziker EB. Release kinetics of transforming growth factor-beta1 from fibrin clots. Biotechnol Bioeng. 2003;83(1):121-3. (Pubitemid 36644453)
17. Gwak SJ, Kim SS, Sung K, Han J, Choi CY, Kim BS. Synergistic effect of keratinocyte transplantation and epidermal growth factor delivery on epidermal regeneration. Cell Transplant. 2005;14(10):809-17. (Pubitemid 43152985)
18. Briganti E, Spiller D, Mirtelli C, Kull S, Counoupas C, Losi P, et al. A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors. J Control Release. 2010;142(1):14-21.
19. Park JS, Yoon JI, Li H, Moon DC, Han K. Buccal mucosal ulcer healing effect of rhEGF/Eudispert hv hydrogel. Arch Pharm Res. 2003;26(8):659-65. (Pubitemid 43080200)
20. Alemdaroglu C, Degim Z, Celebi N, Zor F, Ozturk S, Erdogan D. An investigation on burn wound healing in rats with chitosan gel formulation containing epidermal growth factor. Burns. 2006;32(3):319-27.
21. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83(3):835.
22. Hardwicke J, Ferguson EL, Moseley R, Stephens P, Thomas DW, Duncan R. Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair. J Control Release. 2008;130(3):275-83.
23. Hardwicke J, Schmaljohann D, Boyce D, Thomas D. Epidermal growth factor therapy and wound healing-past, present and future perspectives. Surgeon. 2008;6(3):172-7.
24. Yang CH, Huang YB, Wu PC, Tsai YH. The evaluation of stability of recombinant human epidermal growth factor in burninjured pigs. Process Biochem. 2005;40(5):1661-5.
25. Buckley A, Davidson JM, Kamerath CD, Woodward SC. Epidermal growth factor increases granulation tissue formation dose dependently. J Surg Res. 1987;43(4):322-8. (Pubitemid 18022035)
26. Hori K, Sotozono C, Hamuro J, Yamasaki K, Kimura Y, Ozeki M, et al. Controlled-release of epidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing. J Control Release. 2007;118(2):169-76. (Pubitemid 46329733)
27. Yang CH. Evaluation of the release rate of bioactive recombinant human epidermal growth factor from crosslinking collagen sponges. J Mater Sci Mater Med. 2008;19(3):1433-40.
28. Zhang S, Uludag H. Nanoparticulate systems for growth factor delivery. Pharm Res. 2009;26(7):1561-80.
29. Schultz CL, Morck DW. Contact lenses as a drug delivery device for epidermal growth factor in the treatment of ocular wounds. Clin Exp Optom. 2010;93(2):61-5.
30. Cetin M, Aktas Y, Vural I, Capan Y, Dogan LA, Duman M, et al. Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles. Drug Deliv. 2007;14(8):525-9. (Pubitemid 350135855)
31. Amidi M, Mastrobattista E, Jiskoot W, Hennink WE. Chitosanbased delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev. 2010;62(1):59-82.
32. Masuoka K, Ishihara M, Asazuma T, Hattori H, Matsui T, Takase B, et al. The interaction of chitosan with fibroblast growth factor-2 and its protection from inactivation. Biomaterials. 2005;26(16):3277-84. (Pubitemid 39647261)
33. Zhou S, Deng X, Li X. Investigation on a novel core-coated microspheres protein delivery system. J Control Release. 2001;75(1-2):27-36. (Pubitemid 32635194)
34. Spicer PP, Mikos AG. Fibrin glue as a drug delivery system. J Control Release. 2010;148(1):49-55.
35. Jeon O, Ryu SH, Chung JH, Kim BS. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J Control Release. 2005;105(3):249-59. (Pubitemid 40941990)
36. Lee SB, Geroski DH, Prausnitz MR, Edelhauser HF. Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems. Exp Eye Res. 2004;78(3):599-607. (Pubitemid 38183339)
37. Sekiyama E, Nakamura T, Kurihara E, Cooper LJ, Fullwood NJ, Takaoka M, et al. Novel sutureless transplantation of bioadhesive-coated, freeze-dried amniotic membrane for ocular surface reconstruction. Invest Ophthalmol Vis Sci. 2007;48(4):1528-34. (Pubitemid 351261335)